Cargando…

Engineering of Aspergillus niger for the production of secondary metabolites

BACKGROUND: Filamentous fungi can each produce dozens of secondary metabolites which are attractive as therapeutics, drugs, antimicrobials, flavour compounds and other high-value chemicals. Furthermore, they can be used as an expression system for eukaryotic proteins. Application of most fungal seco...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Lennart, Wanka, Franziska, Boecker, Simon, Storm, Dirk, Kurt, Tutku, Vural, Özlem, Süßmuth, Roderich, Meyer, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598268/
https://www.ncbi.nlm.nih.gov/pubmed/28955446
http://dx.doi.org/10.1186/s40694-014-0004-9
_version_ 1783263869942104064
author Richter, Lennart
Wanka, Franziska
Boecker, Simon
Storm, Dirk
Kurt, Tutku
Vural, Özlem
Süßmuth, Roderich
Meyer, Vera
author_facet Richter, Lennart
Wanka, Franziska
Boecker, Simon
Storm, Dirk
Kurt, Tutku
Vural, Özlem
Süßmuth, Roderich
Meyer, Vera
author_sort Richter, Lennart
collection PubMed
description BACKGROUND: Filamentous fungi can each produce dozens of secondary metabolites which are attractive as therapeutics, drugs, antimicrobials, flavour compounds and other high-value chemicals. Furthermore, they can be used as an expression system for eukaryotic proteins. Application of most fungal secondary metabolites is, however, so far hampered by the lack of suitable fermentation protocols for the producing strain and/or by low product titers. To overcome these limitations, we report here the engineering of the industrial fungus Aspergillus niger to produce high titers (up to 4,500 mg • l(−1)) of secondary metabolites belonging to the class of nonribosomal peptides. RESULTS: For a proof-of-concept study, we heterologously expressed the 351 kDa nonribosomal peptide synthetase ESYN from Fusarium oxysporum in A. niger. ESYN catalyzes the formation of cyclic depsipeptides of the enniatin family, which exhibit antimicrobial, antiviral and anticancer activities. The encoding gene esyn1 was put under control of a tunable bacterial-fungal hybrid promoter (Tet-on) which was switched on during early-exponential growth phase of A. niger cultures. The enniatins were isolated and purified by means of reverse phase chromatography and their identity and purity proven by tandem MS, NMR spectroscopy and X-ray crystallography. The initial yields of 1 mg • l(−1) of enniatin were increased about 950 fold by optimizing feeding conditions and the morphology of A. niger in liquid shake flask cultures. Further yield optimization (about 4.5 fold) was accomplished by cultivating A. niger in 5 l fed batch fermentations. Finally, an autonomous A. niger expression host was established, which was independent from feeding with the enniatin precursor d-2-hydroxyvaleric acid d-Hiv. This was achieved by constitutively expressing a fungal d-Hiv dehydrogenase in the esyn1-expressing A. niger strain, which used the intracellular α-ketovaleric acid pool to generate d-Hiv. CONCLUSIONS: This is the first report demonstrating that A. niger is a potent and promising expression host for nonribosomal peptides with titers high enough to become industrially attractive. Application of the Tet-on system in A. niger allows precise control on the timing of product formation, thereby ensuring high yields and purity of the peptides produced. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40694-014-0004-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5598268
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55982682017-09-27 Engineering of Aspergillus niger for the production of secondary metabolites Richter, Lennart Wanka, Franziska Boecker, Simon Storm, Dirk Kurt, Tutku Vural, Özlem Süßmuth, Roderich Meyer, Vera Fungal Biol Biotechnol Research BACKGROUND: Filamentous fungi can each produce dozens of secondary metabolites which are attractive as therapeutics, drugs, antimicrobials, flavour compounds and other high-value chemicals. Furthermore, they can be used as an expression system for eukaryotic proteins. Application of most fungal secondary metabolites is, however, so far hampered by the lack of suitable fermentation protocols for the producing strain and/or by low product titers. To overcome these limitations, we report here the engineering of the industrial fungus Aspergillus niger to produce high titers (up to 4,500 mg • l(−1)) of secondary metabolites belonging to the class of nonribosomal peptides. RESULTS: For a proof-of-concept study, we heterologously expressed the 351 kDa nonribosomal peptide synthetase ESYN from Fusarium oxysporum in A. niger. ESYN catalyzes the formation of cyclic depsipeptides of the enniatin family, which exhibit antimicrobial, antiviral and anticancer activities. The encoding gene esyn1 was put under control of a tunable bacterial-fungal hybrid promoter (Tet-on) which was switched on during early-exponential growth phase of A. niger cultures. The enniatins were isolated and purified by means of reverse phase chromatography and their identity and purity proven by tandem MS, NMR spectroscopy and X-ray crystallography. The initial yields of 1 mg • l(−1) of enniatin were increased about 950 fold by optimizing feeding conditions and the morphology of A. niger in liquid shake flask cultures. Further yield optimization (about 4.5 fold) was accomplished by cultivating A. niger in 5 l fed batch fermentations. Finally, an autonomous A. niger expression host was established, which was independent from feeding with the enniatin precursor d-2-hydroxyvaleric acid d-Hiv. This was achieved by constitutively expressing a fungal d-Hiv dehydrogenase in the esyn1-expressing A. niger strain, which used the intracellular α-ketovaleric acid pool to generate d-Hiv. CONCLUSIONS: This is the first report demonstrating that A. niger is a potent and promising expression host for nonribosomal peptides with titers high enough to become industrially attractive. Application of the Tet-on system in A. niger allows precise control on the timing of product formation, thereby ensuring high yields and purity of the peptides produced. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40694-014-0004-9) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-14 /pmc/articles/PMC5598268/ /pubmed/28955446 http://dx.doi.org/10.1186/s40694-014-0004-9 Text en © Richter et al.; licensee BioMed Central 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Richter, Lennart
Wanka, Franziska
Boecker, Simon
Storm, Dirk
Kurt, Tutku
Vural, Özlem
Süßmuth, Roderich
Meyer, Vera
Engineering of Aspergillus niger for the production of secondary metabolites
title Engineering of Aspergillus niger for the production of secondary metabolites
title_full Engineering of Aspergillus niger for the production of secondary metabolites
title_fullStr Engineering of Aspergillus niger for the production of secondary metabolites
title_full_unstemmed Engineering of Aspergillus niger for the production of secondary metabolites
title_short Engineering of Aspergillus niger for the production of secondary metabolites
title_sort engineering of aspergillus niger for the production of secondary metabolites
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598268/
https://www.ncbi.nlm.nih.gov/pubmed/28955446
http://dx.doi.org/10.1186/s40694-014-0004-9
work_keys_str_mv AT richterlennart engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT wankafranziska engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT boeckersimon engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT stormdirk engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT kurttutku engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT vuralozlem engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT sußmuthroderich engineeringofaspergillusnigerfortheproductionofsecondarymetabolites
AT meyervera engineeringofaspergillusnigerfortheproductionofsecondarymetabolites